News

The Pharma Letter17m
NextCure tanks as it teams up with Simcere on novel ADC
Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...
The Pharma Letter47m
Teva and Fosun ink deal on TEV-56278 development
Israel’s Teva Pharmaceutical Industries and Shanghai Fosun Pharmaceutical have entered a strategic partnership for the ...
The Pharma Letter57m
Maxion names Stefan Härtle as chief development officer
Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...